BCRX · BioCryst Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Jon P. Stonehouse President & CEO | ▲ Buy | Grant | 1,340,419 Shares held | 8/31/2026 | View profile |
| Charles K. Gayer Chief Commercial Officer | ▲ Buy | Option Exercise | 952,583 Shares held | 12/22/2025 | View profile |
| Alane P. Barnes Chief Legal Officer | ▼ Sell | Open Market | 400,703 Shares held | 5/13/2026 | View profile |
| Doyle Anthony Chief Financial Officer | ▼ Sell | Tax Withholding | 377,867 Shares held | 12/19/2024 | View profile |
| Thackray Helen M. Chief R&D Officer | ▼ Sell | Tax Withholding | 377,318 Shares held | 3/31/2025 | View profile |
| Babu Yarlagadda S Chief Discovery Officer | ▼ Sell | Open Market | 298,541 Shares held | 11/14/2022 | View profile |
| Babar Ghias CFO & Head of Corp Development | ▲ Buy | Grant | 268,700 Shares held | 12/17/2025 | View profile |
| Sandeep Menon Chief R&D Officer | ▲ Buy | Grant | 205,150 Shares held | 4/6/2026 | View profile |
| Vincent Milano Director | ▲ Buy | Grant | 109,642 Shares held | 8/31/2026 | View profile |
| INGRAM ROBERT ALEXANDER Director | ▲ Buy | Grant | 100,198 Shares held | 2/28/2023 | View profile |
| Hutson Nancy J Director | ▲ Buy | Grant | 99,138 Shares held | 6/12/2025 | View profile |
| Theresa Heggie Director | ▲ Buy | Grant | 80,646 Shares held | 6/11/2026 | View profile |
| Alan G. Levin Director | ▲ Buy | Grant | 79,565 Shares held | 6/11/2026 | View profile |
| ASELAGE STEVE Director | ▲ Buy | Grant | 70,159 Shares held | 6/12/2024 | View profile |
| LEE KENNETH B JR Director | ▲ Buy | Grant | 68,863 Shares held | 6/13/2023 | View profile |
| Amy E. McKee Director | ▲ Buy | Grant | 47,821 Shares held | 8/31/2026 | View profile |
| MacHelle Sanders Director | ▲ Buy | Grant | 45,936 Shares held | 6/11/2026 | View profile |
| Sheridan William P Chief Medical Officer | ▼ Sell | Open Market | 37,954 Shares held | 3/10/2022 | View profile |
| Steven Frank Director | ▲ Buy | Grant | 36,747 Shares held | 8/31/2026 | View profile |
| ABERCROMBIE GEORGE B Director | ▲ Buy | Grant | 36,431 Shares held | 6/12/2024 | View profile |
| Jill C. Milne Director | ▲ Buy | Grant | 33,226 Shares held | 8/31/2026 | View profile |
| Steven K. Galson Director | ▲ Buy | Grant | 27,794 Shares held | 6/11/2026 | View profile |
| Jones Michael L Exec. Director, Finance - PAO | ▲ Buy | Grant | 16,653 Shares held | 12/19/2022 | View profile |
Transaction History
| Amy E. McKee | ▲ Buy | Grant | 644 | $6K | 8/31/2026 |
| Steven Frank | ▲ Buy | Grant | 1,288 | $12K | 8/31/2026 |
| Vincent Milano | ▲ Buy | Grant | 1,159 | $11K | 8/31/2026 |
| Jill C. Milne | ▲ Buy | Grant | 1,288 | $12K | 8/31/2026 |
| Jon P. Stonehouse | ▲ Buy | Grant | 644 | $6K | 8/31/2026 |
| Jill C. Milne | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Steven K. Galson | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Alan G. Levin | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Steven Frank | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| MacHelle Sanders | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Vincent Milano | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Jon P. Stonehouse | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Amy E. McKee | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Theresa Heggie | ▲ Buy | Grant | 15,294 | $0 | 6/11/2026 |
| Jill C. Milne | ▲ Buy | Grant | 1,262 | $11K | 5/29/2026 |
| Jon P. Stonehouse | ▲ Buy | Grant | 631 | $6K | 5/29/2026 |
| Amy E. McKee | ▲ Buy | Grant | 631 | $6K | 5/29/2026 |
| Vincent Milano | ▲ Buy | Grant | 1,122 | $10K | 5/29/2026 |
| Steven Frank | ▲ Buy | Grant | 1,262 | $11K | 5/29/2026 |
| Amy E. McKee | ▼ Sell | Open Market | 11,180 | $100K | 5/18/2026 |
| Alane P. Barnes | ▲ Buy | Option Exercise | 62,500 | $315K | 5/13/2026 |
| Alane P. Barnes | ▼ Sell | Open Market | 62,500 | $596K | 5/13/2026 |
| Sandeep Menon | ▲ Buy | Grant | 205,150 | $0 | 4/6/2026 |
| Theresa Heggie | ▲ Buy | Option Exercise | 49,933 | $315K | 3/20/2026 |
| Theresa Heggie | ▼ Sell | Open Market | 49,933 | $505K | 3/20/2026 |
| Alane P. Barnes | ▲ Buy | Option Exercise | 150,000 | $827K | 3/16/2026 |
| Alane P. Barnes | ▼ Sell | Open Market | 150,000 | $1.4M | 3/16/2026 |
| Jon P. Stonehouse | ▲ Buy | Option Exercise | 305,995 | $985K | 3/2/2026 |
| Jon P. Stonehouse | ▼ Sell | Other | 305,995 | $2.6M | 3/2/2026 |
| Jill C. Milne | ▲ Buy | Grant | 528 | $5K | 2/27/2026 |
| Jon P. Stonehouse | ▲ Buy | Grant | 421 | $4K | 2/27/2026 |
| Vincent Milano | ▲ Buy | Grant | 848 | $7K | 2/27/2026 |
| Steven Frank | ▲ Buy | Grant | 1,285 | $11K | 2/27/2026 |
| Amy E. McKee | ▲ Buy | Grant | 642 | $6K | 2/27/2026 |
| Jill C. Milne | ▲ Buy | Grant | 2,582 | — | 1/23/2026 |
| Jill C. Milne | ▲ Buy | Grant | 12,272 | $0 | 1/23/2026 |
| Alane P. Barnes | ▼ Sell | Open Market | 21,773 | $167K | 12/22/2025 |
| Charles K. Gayer | ▲ Buy | Option Exercise | 14,142 | $46K | 12/22/2025 |
| Charles K. Gayer | ▲ Buy | Option Exercise | 10,091 | $51K | 12/22/2025 |
| Charles K. Gayer | ▲ Buy | Option Exercise | 50,000 | $276K | 12/22/2025 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 61,793 | $458K | 12/19/2025 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 16,902 | $125K | 12/19/2025 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 11,477 | $85K | 12/19/2025 |
| Jon P. Stonehouse | ▼ Sell | Gift | 20,000 | $0 | 12/18/2025 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 12/18/2025 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 12/18/2025 |
| Charles K. Gayer | ▲ Buy | Grant | 471,000 | $0 | 12/17/2025 |
| Alane P. Barnes | ▲ Buy | Grant | 121,700 | $0 | 12/17/2025 |
| Babar Ghias | ▲ Buy | Grant | 121,700 | $0 | 12/17/2025 |
| Alane P. Barnes | ▼ Sell | Open Market | 21,210 | $162K | 12/15/2025 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 8,181 | $62K | 12/12/2025 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 8,540 | $65K | 12/12/2025 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 27,368 | $207K | 12/12/2025 |
| Alane P. Barnes | ▼ Sell | Open Market | 19,770 | $151K | 12/3/2025 |
| Alane P. Barnes | ▼ Sell | Open Market | 50,906 | $367K | 12/2/2025 |
| Alane P. Barnes | ▲ Buy | Option Exercise | 91,004 | $293K | 12/1/2025 |
| Alane P. Barnes | ▼ Sell | Open Market | 91,004 | $647K | 12/1/2025 |
| Amy E. McKee | ▲ Buy | Grant | 783 | $6K | 11/28/2025 |
| Steven Frank | ▲ Buy | Grant | 1,566 | $11K | 11/28/2025 |
| Vincent Milano | ▲ Buy | Grant | 783 | $6K | 11/28/2025 |
| MacHelle Sanders | ▼ Sell | Open Market | 9,600 | $69K | 11/13/2025 |
| Steven Frank | ▲ Buy | Grant | 1,353 | $11K | 8/29/2025 |
| Vincent Milano | ▲ Buy | Grant | 676 | $6K | 8/29/2025 |
| Amy E. McKee | ▲ Buy | Grant | 676 | $6K | 8/29/2025 |
| Theresa Heggie | ▲ Buy | Option Exercise | 30,000 | $87K | 8/13/2025 |
| Theresa Heggie | ▲ Buy | Option Exercise | 40,000 | $216K | 8/13/2025 |
| Theresa Heggie | ▼ Sell | Open Market | 70,000 | $596K | 8/13/2025 |
| Babar Ghias | ▲ Buy | Grant | 147,000 | $0 | 7/24/2025 |
| Amy E. McKee | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Theresa Heggie | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Steven K. Galson | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Vincent Milano | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| MacHelle Sanders | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Hutson Nancy J | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Steven Frank | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Alan G. Levin | ▲ Buy | Grant | 12,500 | $0 | 6/12/2025 |
| Vincent Milano | ▲ Buy | Grant | 523 | $6K | 5/30/2025 |
| Steven Frank | ▲ Buy | Grant | 333 | $4K | 5/30/2025 |
| Steven Frank | ▲ Buy | Grant | 1,866 | $0 | 5/2/2025 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 7,525 | $56K | 3/31/2025 |
| Vincent Milano | ▲ Buy | Grant | 653 | $6K | 2/28/2025 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 12/20/2024 |
| Jon P. Stonehouse | ▼ Sell | Gift | 20,000 | $0 | 12/20/2024 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 12/20/2024 |
| Charles K. Gayer | ▲ Buy | Grant | 125,950 | $0 | 12/19/2024 |
| Doyle Anthony | ▲ Buy | Grant | 120,700 | $0 | 12/19/2024 |
| Doyle Anthony | ▼ Sell | Tax Withholding | 2,461 | $18K | 12/19/2024 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 2,461 | $18K | 12/19/2024 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 14,010 | $104K | 12/19/2024 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 2,461 | $18K | 12/19/2024 |
| Alane P. Barnes | ▲ Buy | Grant | 120,700 | $0 | 12/19/2024 |
| Jon P. Stonehouse | ▲ Buy | Grant | 362,100 | $0 | 12/19/2024 |
| Thackray Helen M. | ▲ Buy | Grant | 125,950 | $0 | 12/19/2024 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 6,096 | $45K | 12/19/2024 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 8,251 | $62K | 12/14/2024 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 27,525 | $207K | 12/14/2024 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 8,613 | $65K | 12/14/2024 |
| Doyle Anthony | ▼ Sell | Tax Withholding | 7,890 | $59K | 12/14/2024 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 7,150 | $54K | 12/14/2024 |
| Hutson Nancy J | ▼ Sell | Open Market | 7,000 | $53K | 12/13/2024 |
| Vincent Milano | ▲ Buy | Grant | 750 | $6K | 11/29/2024 |
| Vincent Milano | ▲ Buy | Grant | 647 | $6K | 8/30/2024 |
| Amy E. McKee | ▼ Sell | Open Market | 8,600 | $54K | 6/24/2024 |
| MacHelle Sanders | ▼ Sell | Open Market | 4,689 | $28K | 6/17/2024 |
| Theresa Heggie | ▼ Sell | Open Market | 6,698 | $41K | 6/14/2024 |
| Amy E. McKee | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Alan G. Levin | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Hutson Nancy J | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| ASELAGE STEVE | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Theresa Heggie | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Steven K. Galson | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Vincent Milano | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| MacHelle Sanders | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| ABERCROMBIE GEORGE B | ▲ Buy | Grant | 6,820 | $0 | 6/12/2024 |
| Theresa Heggie | ▲ Buy | Grant | 870 | $6K | 5/31/2024 |
| Vincent Milano | ▲ Buy | Grant | 870 | $6K | 5/31/2024 |
| Alan G. Levin | ▲ Buy | Open Market | 7,861 | $50K | 5/30/2024 |
| ASELAGE STEVE | ▲ Buy | Open Market | 2,500 | $16K | 5/24/2024 |
| Vincent Milano | ▲ Buy | Open Market | 15,000 | $94K | 5/20/2024 |
| Hutson Nancy J | ▲ Buy | Open Market | 5,000 | $32K | 5/20/2024 |
| Thackray Helen M. | ▲ Buy | Open Market | 30,000 | $176K | 5/14/2024 |
| Doyle Anthony | ▲ Buy | Open Market | 36,300 | $202K | 5/14/2024 |
| Alane P. Barnes | ▲ Buy | Open Market | 5,000 | $28K | 5/13/2024 |
| Jon P. Stonehouse | ▲ Buy | Open Market | 30,000 | $167K | 5/13/2024 |
| Charles K. Gayer | ▲ Buy | Open Market | 30,000 | $164K | 5/13/2024 |
| Steven K. Galson | ▲ Buy | Open Market | 21,940 | $120K | 5/13/2024 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 7,525 | $38K | 3/31/2024 |
| Theresa Heggie | ▲ Buy | Grant | 999 | $6K | 2/29/2024 |
| Vincent Milano | ▲ Buy | Grant | 999 | $6K | 2/29/2024 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 1/3/2024 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 1/3/2024 |
| Jon P. Stonehouse | ▼ Sell | Gift | 20,000 | $0 | 1/3/2024 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 5,580 | $34K | 12/19/2023 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 2,482 | $15K | 12/19/2023 |
| Doyle Anthony | ▼ Sell | Tax Withholding | 2,482 | $15K | 12/19/2023 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 2,482 | $15K | 12/19/2023 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 14,089 | $85K | 12/19/2023 |
| Thackray Helen M. | ▼ Sell | Tax Withholding | 3,031 | $19K | 12/14/2023 |
| Jon P. Stonehouse | ▼ Sell | Tax Withholding | 13,592 | $87K | 12/14/2023 |
| Charles K. Gayer | ▼ Sell | Tax Withholding | 5,840 | $38K | 12/14/2023 |
| Doyle Anthony | ▼ Sell | Tax Withholding | 5,475 | $35K | 12/14/2023 |
| Alane P. Barnes | ▼ Sell | Tax Withholding | 4,015 | $26K | 12/14/2023 |
| Doyle Anthony | ▲ Buy | Grant | 34,000 | $0 | 12/14/2023 |
| Charles K. Gayer | ▲ Buy | Grant | 34,000 | $0 | 12/14/2023 |
| Thackray Helen M. | ▲ Buy | Grant | 51,000 | $0 | 12/14/2023 |
| Alane P. Barnes | ▲ Buy | Grant | 64,000 | $0 | 12/14/2023 |
| Jon P. Stonehouse | ▲ Buy | Grant | 127,500 | $0 | 12/14/2023 |
| Vincent Milano | ▲ Buy | Grant | 956 | $6K | 11/30/2023 |
| Theresa Heggie | ▲ Buy | Grant | 956 | $6K | 11/30/2023 |
| Vincent Milano | ▲ Buy | Grant | 791 | $6K | 8/31/2023 |
| Theresa Heggie | ▲ Buy | Grant | 791 | $6K | 8/31/2023 |
| MacHelle Sanders | ▼ Sell | Open Market | 4,000 | $32K | 6/15/2023 |
| Hutson Nancy J | ▼ Sell | Open Market | 12,866 | $103K | 6/14/2023 |
| ASELAGE STEVE | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Theresa Heggie | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| ABERCROMBIE GEORGE B | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Amy E. McKee | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| MacHelle Sanders | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| LEE KENNETH B JR | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Vincent Milano | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Hutson Nancy J | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Alan G. Levin | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Steven K. Galson | ▲ Buy | Grant | 16,745 | $0 | 6/13/2023 |
| Jon P. Stonehouse | ▼ Sell | Gift | 25,000 | $0 | 6/13/2023 |
| Vincent Milano | ▲ Buy | Grant | 680 | $6K | 5/31/2023 |
| Alan G. Levin | ▲ Buy | Grant | 1,360 | $11K | 5/31/2023 |
| Theresa Heggie | ▲ Buy | Grant | 680 | $6K | 5/31/2023 |
| Thackray Helen M. | ▼ Sell | Open Market | 7,000 | $58K | 4/3/2023 |
| Jon P. Stonehouse | ▲ Buy | Option Exercise | 31,055 | $100K | 3/21/2023 |
| Theresa Heggie | ▲ Buy | Grant | 635 | $6K | 2/28/2023 |
| Alan G. Levin | ▲ Buy | Grant | 1,271 | $11K | 2/28/2023 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 2,259 | $20K | 2/28/2023 |
| Vincent Milano | ▲ Buy | Grant | 635 | $6K | 2/28/2023 |
| Jon P. Stonehouse | ▲ Buy | Option Exercise | 100,000 | $545K | 2/1/2023 |
| Jon P. Stonehouse | ▼ Sell | Open Market | 100,000 | $1.0M | 2/1/2023 |
| LEE KENNETH B JR | ▲ Buy | Option Exercise | 15,000 | $26K | 1/31/2023 |
| Jon P. Stonehouse | ▼ Sell | Gift | 5,000 | $0 | 12/29/2022 |
| Jon P. Stonehouse | ▼ Sell | Gift | 5,000 | $0 | 12/29/2022 |
| Jon P. Stonehouse | ▼ Sell | Gift | 10,000 | $0 | 12/29/2022 |
| Thackray Helen M. | ▲ Buy | Grant | 81,000 | $0 | 12/19/2022 |
| Jon P. Stonehouse | ▲ Buy | Grant | 127,500 | $0 | 12/19/2022 |
| Charles K. Gayer | ▲ Buy | Grant | 34,000 | $0 | 12/19/2022 |
| Alane P. Barnes | ▲ Buy | Grant | 34,000 | $0 | 12/19/2022 |
| Jones Michael L | ▲ Buy | Grant | 5,900 | $0 | 12/19/2022 |
| Doyle Anthony | ▲ Buy | Grant | 34,000 | $0 | 12/19/2022 |
| Jon P. Stonehouse | ▼ Sell | Open Market | 14,100 | $154K | 12/15/2022 |
| Charles K. Gayer | ▼ Sell | Open Market | 6,100 | $66K | 12/15/2022 |
| Alane P. Barnes | ▼ Sell | Open Market | 4,175 | $45K | 12/15/2022 |
| Doyle Anthony | ▼ Sell | Open Market | 5,700 | $62K | 12/15/2022 |
| Thackray Helen M. | ▼ Sell | Open Market | 3,125 | $34K | 12/15/2022 |
| Jones Michael L | ▼ Sell | Open Market | 445 | $5K | 12/15/2022 |
| Jon P. Stonehouse | ▲ Buy | Option Exercise | 82,656 | $117K | 12/2/2022 |
| Jon P. Stonehouse | ▼ Sell | Open Market | 82,656 | $1.1M | 12/2/2022 |
| Jones Michael L | ▲ Buy | Option Exercise | 8,600 | $12K | 12/1/2022 |
| Jones Michael L | ▼ Sell | Open Market | 8,600 | $112K | 12/1/2022 |
| Jon P. Stonehouse | ▲ Buy | Option Exercise | 214,917 | $305K | 12/1/2022 |
| Jon P. Stonehouse | ▼ Sell | Open Market | 214,917 | $2.8M | 12/1/2022 |
| Alan G. Levin | ▲ Buy | Grant | 842 | $11K | 11/30/2022 |
| INGRAM ROBERT ALEXANDER | ▲ Buy | Grant | 1,497 | $20K | 11/30/2022 |
| Theresa Heggie | ▲ Buy | Grant | 421 | $6K | 11/30/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
BCRX Trades at 11x Forward Earnings, Analysts See $20.73 Target
BCRX is currently trading at about 11 times its forward earnings, which is on the lower side for the biotech sector. Analysts have an average target of $20.73, with a range from $11 to $32, while the stock sits near the bottom of its 52‑week range. This valuation gap raises questions about whether the market is pricing in potential challenges for the company.
BCRX Trades at 11x Forward Earnings, Analysts See $20.73 Target. BCRX is currently trading at about 11 times its forward earnings, which is on the lower side for the biotech sector. Analysts have an average target of $20.73, with a range from $11 to $32, while the stock sits near the bottom of its 52‑week range. This valuation gap raises questions about whether the market is pricing in potential challenges for the company.